Cargando…

Validation of the VERITAS-Pro treatment adherence scale in a Spanish sample population with hemophilia

PURPOSE: We aimed to conduct a validation in Spanish of the Validated Hemophilia Regimen Treatment Adherence Scale – Prophylaxis (VERITAS-Pro) questionnaire for use in patients with hemophilia under prophylactic treatment. PATIENTS AND METHODS: The VERITAS-Pro scale was adapted through a process of...

Descripción completa

Detalles Bibliográficos
Autores principales: Cuesta-Barriuso, Rubén, Torres-Ortuño, Ana, Galindo-Piñana, Pilar, Nieto-Munuera, Joaquín, Duncan, Natalie, López-Pina, José Antonio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5375636/
https://www.ncbi.nlm.nih.gov/pubmed/28392680
http://dx.doi.org/10.2147/PPA.S126828
_version_ 1782519034252623872
author Cuesta-Barriuso, Rubén
Torres-Ortuño, Ana
Galindo-Piñana, Pilar
Nieto-Munuera, Joaquín
Duncan, Natalie
López-Pina, José Antonio
author_facet Cuesta-Barriuso, Rubén
Torres-Ortuño, Ana
Galindo-Piñana, Pilar
Nieto-Munuera, Joaquín
Duncan, Natalie
López-Pina, José Antonio
author_sort Cuesta-Barriuso, Rubén
collection PubMed
description PURPOSE: We aimed to conduct a validation in Spanish of the Validated Hemophilia Regimen Treatment Adherence Scale – Prophylaxis (VERITAS-Pro) questionnaire for use in patients with hemophilia under prophylactic treatment. PATIENTS AND METHODS: The VERITAS-Pro scale was adapted through a process of back translation from English to Spanish. A bilingual native Spanish translator translated the scale from English to Spanish. Subsequently, a bilingual native English translator translated the scale from Spanish to English. The disagreements were resolved by agreement between the research team and translators. Seventy-three patients with hemophilia, aged 13–62 years, were enrolled in the study. The scale was applied twice (2 months apart) to evaluate the test–retest reliability. RESULTS: Internal consistency reliability was lower on the Spanish VERITAS-Pro than on the English version. Test–retest reliability was high, ranging from 0.83 to 0.92. No significant differences (P>0.05) were found between test and retest scores in subscales of VERITAS-Pro. In general, Spanish patients showed higher rates of nonadherence than American patients in all subscales. CONCLUSION: The Spanish version of the VERITAS-Pro has high levels of consistency and empirical validity. This scale can be administered to assess the degree of adherence of prophylactic treatment in patients with hemophilia.
format Online
Article
Text
id pubmed-5375636
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-53756362017-04-07 Validation of the VERITAS-Pro treatment adherence scale in a Spanish sample population with hemophilia Cuesta-Barriuso, Rubén Torres-Ortuño, Ana Galindo-Piñana, Pilar Nieto-Munuera, Joaquín Duncan, Natalie López-Pina, José Antonio Patient Prefer Adherence Original Research PURPOSE: We aimed to conduct a validation in Spanish of the Validated Hemophilia Regimen Treatment Adherence Scale – Prophylaxis (VERITAS-Pro) questionnaire for use in patients with hemophilia under prophylactic treatment. PATIENTS AND METHODS: The VERITAS-Pro scale was adapted through a process of back translation from English to Spanish. A bilingual native Spanish translator translated the scale from English to Spanish. Subsequently, a bilingual native English translator translated the scale from Spanish to English. The disagreements were resolved by agreement between the research team and translators. Seventy-three patients with hemophilia, aged 13–62 years, were enrolled in the study. The scale was applied twice (2 months apart) to evaluate the test–retest reliability. RESULTS: Internal consistency reliability was lower on the Spanish VERITAS-Pro than on the English version. Test–retest reliability was high, ranging from 0.83 to 0.92. No significant differences (P>0.05) were found between test and retest scores in subscales of VERITAS-Pro. In general, Spanish patients showed higher rates of nonadherence than American patients in all subscales. CONCLUSION: The Spanish version of the VERITAS-Pro has high levels of consistency and empirical validity. This scale can be administered to assess the degree of adherence of prophylactic treatment in patients with hemophilia. Dove Medical Press 2017-03-27 /pmc/articles/PMC5375636/ /pubmed/28392680 http://dx.doi.org/10.2147/PPA.S126828 Text en © 2017 Cuesta-Barriuso et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Original Research
Cuesta-Barriuso, Rubén
Torres-Ortuño, Ana
Galindo-Piñana, Pilar
Nieto-Munuera, Joaquín
Duncan, Natalie
López-Pina, José Antonio
Validation of the VERITAS-Pro treatment adherence scale in a Spanish sample population with hemophilia
title Validation of the VERITAS-Pro treatment adherence scale in a Spanish sample population with hemophilia
title_full Validation of the VERITAS-Pro treatment adherence scale in a Spanish sample population with hemophilia
title_fullStr Validation of the VERITAS-Pro treatment adherence scale in a Spanish sample population with hemophilia
title_full_unstemmed Validation of the VERITAS-Pro treatment adherence scale in a Spanish sample population with hemophilia
title_short Validation of the VERITAS-Pro treatment adherence scale in a Spanish sample population with hemophilia
title_sort validation of the veritas-pro treatment adherence scale in a spanish sample population with hemophilia
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5375636/
https://www.ncbi.nlm.nih.gov/pubmed/28392680
http://dx.doi.org/10.2147/PPA.S126828
work_keys_str_mv AT cuestabarriusoruben validationoftheveritasprotreatmentadherencescaleinaspanishsamplepopulationwithhemophilia
AT torresortunoana validationoftheveritasprotreatmentadherencescaleinaspanishsamplepopulationwithhemophilia
AT galindopinanapilar validationoftheveritasprotreatmentadherencescaleinaspanishsamplepopulationwithhemophilia
AT nietomunuerajoaquin validationoftheveritasprotreatmentadherencescaleinaspanishsamplepopulationwithhemophilia
AT duncannatalie validationoftheveritasprotreatmentadherencescaleinaspanishsamplepopulationwithhemophilia
AT lopezpinajoseantonio validationoftheveritasprotreatmentadherencescaleinaspanishsamplepopulationwithhemophilia